Human gene therapy - JoVE Visualize

Showing results (1901-1910 of 4,124) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|July 29, 1998

Extensive cross-reactivity of adenovirus-specific cytotoxic T cellsC A Smith, L S Woodruff, C Rooney, et al.

Human Gene Therapy|July 29, 1998

Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive ratsK F Lin, J Chao, L Chao

Human Gene Therapy|July 29, 1998

High-efficiency retrovirus-mediated gene transfer into the livers of miceG A Patijn, A Lieber, L Meuse, et al.

Human Gene Therapy|August 28, 1998

Effects of keratinocyte and hepatocyte growth factor in vivo: implications for retrovirus-mediated gene transfer to liverA Bosch, P B McCray, K S Walters, et al.

Human Gene Therapy|June 20, 2012

Combined fiber modifications both to target α(v)β(6) and detarget the coxsackievirus-adenovirus receptor improve virus toxicity profiles in vivo but fail to improve antitumoral efficacy relative to adenovirus serotype 5Lynda Coughlan, Sabari Vallath, Alena Gros, et al.

Human Gene Therapy|April 2, 2015

Gene therapy for inherited diseases of liver metabolismPasquale Piccolo, Nicola Brunetti-Pierri

Human Gene Therapy|March 12, 2015

Cytokine-induced killer cells engineered with exogenous T-cell receptors directed against melanoma antigens: enhanced efficacy of effector cells endowed with a double mechanism of tumor recognitionAngela R Elia, Paola Circosta, Dario Sangiolo, et al.

Human Gene Therapy|April 11, 2015

Clinical applications of gene therapy for primary immunodeficienciesMaria Pia Cicalese, Alessandro Aiuti

Human Gene Therapy|April 11, 2015

Adoptive T-cell therapy for cancer in the United kingdom: a review of activity for the British Society of Gene and Cell Therapy annual meeting 2015David Edward Gilham, John Anderson, John Stephen Bridgeman, et al.

Human Gene Therapy|August 16, 2012

Engineered zinc-finger proteins can compensate genetic haploinsufficiency by transcriptional activation of the wild-type allele: application to Willams-Beuren syndrome and supravalvular aortic stenosisPei Zhang, Angela Huang, Manuel Morales-Ruiz, et al.

Pageof 413

Showing results (1901-1910 of 4,124) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|July 29, 1998

Extensive cross-reactivity of adenovirus-specific cytotoxic T cellsC A Smith, L S Woodruff, C Rooney, et al.

Human Gene Therapy|July 29, 1998

Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive ratsK F Lin, J Chao, L Chao

Human Gene Therapy|July 29, 1998

High-efficiency retrovirus-mediated gene transfer into the livers of miceG A Patijn, A Lieber, L Meuse, et al.

Human Gene Therapy|August 28, 1998

Effects of keratinocyte and hepatocyte growth factor in vivo: implications for retrovirus-mediated gene transfer to liverA Bosch, P B McCray, K S Walters, et al.

Human Gene Therapy|June 20, 2012

Combined fiber modifications both to target α(v)β(6) and detarget the coxsackievirus-adenovirus receptor improve virus toxicity profiles in vivo but fail to improve antitumoral efficacy relative to adenovirus serotype 5Lynda Coughlan, Sabari Vallath, Alena Gros, et al.

Human Gene Therapy|April 2, 2015

Gene therapy for inherited diseases of liver metabolismPasquale Piccolo, Nicola Brunetti-Pierri

Human Gene Therapy|March 12, 2015

Cytokine-induced killer cells engineered with exogenous T-cell receptors directed against melanoma antigens: enhanced efficacy of effector cells endowed with a double mechanism of tumor recognitionAngela R Elia, Paola Circosta, Dario Sangiolo, et al.

Human Gene Therapy|April 11, 2015

Clinical applications of gene therapy for primary immunodeficienciesMaria Pia Cicalese, Alessandro Aiuti

Human Gene Therapy|April 11, 2015

Adoptive T-cell therapy for cancer in the United kingdom: a review of activity for the British Society of Gene and Cell Therapy annual meeting 2015David Edward Gilham, John Anderson, John Stephen Bridgeman, et al.

Human Gene Therapy|August 16, 2012

Engineered zinc-finger proteins can compensate genetic haploinsufficiency by transcriptional activation of the wild-type allele: application to Willams-Beuren syndrome and supravalvular aortic stenosisPei Zhang, Angela Huang, Manuel Morales-Ruiz, et al.

Pageof 413